MYCOPHENOLATE MOFETIL-INDUCED PULMONARY NODULES
نویسندگان
چکیده
TOPIC: Imaging TYPE: Medical Student/Resident Case Reports INTRODUCTION: Pulmonary nodules are common and usually found incidentally in about 20-50 % Chest Computed Tomography (CT) scans screening trials.[1] Evaluation of is necessary as differential broad includes malignancy, infectious diseases like tuberculosis (TB), hamartomas, sarcoidosis, wegner's granulomatosis, granulomas.[2] There have been cases reporting mycophenolate mofetil (MMF) induced lymphoproliferative lymphoid neoplasms, mostly central nervous system, rarely lungs, but no which shown only lung lesion the form nodule caused by MMF.[3] We presenting a rare case MMF pulmonary nodules. CASE PRESENTATION: A 73 year non smoker female with 14 history diffuse scleroderma interstitial disease, esophageal dysmotility, Raynaud's disease digital ulceration multiple joint pains, on for 9 years, esomeprazole, antihypertensives intermittently methotrexate nintedanib short period time. She was accidentally to large right shoulder XRay, done evaluation pain. Subsequently CT showed multifocal bilateral mass opacities cavitary lesions, largest apical left upper lobe, measuring 4.4 x 2.7 3.9 cm lower lobe 3.3 3.8 3.1 cm. Positive Emission revealed abnormal uptake 3 lung. 2 weeks Amoxicillin-clavunate followed metronidazole given possibility aspiration pneumonia. interval change XRay. Quantiferon gold TB workup infection vasculitis associated her autoimmune condition were unremarkable. Biopsy negative marked fibrosis predominantly chronic (round cell) inflammatory cell infiltrate parenchyma/bronchial mucosa. Her discontinued. Serial chest at months intervals continual decrease size essentially all masses. DISCUSSION: very differential. In our patient, considerations process, hematogenous or aspiration. remains main diagnostic approach, malignancy. also treated antibiotics pneumonia, though lesions not typical position improvement imaging. Infectious work up Furthermore, after stopping indicates related CONCLUSIONS: patients nodules, should be REFERENCE #1: Au-Yong I T H, Hamilton W, Rawlinson J, Baldwin D R. BMJ 2020; 371 :m3673 doi:10.1136/bmj.m3673 #2: Edward Y. Chan, Puja Gaur, Yimin Ge, Lisa Kopas, Jose F. Santacruz, Nakul Gupta, Reginald Munden, Philip T. Cagle, Min P. Kim; Management Solitary Nodule. Arch Pathol Lab Med 1 July 2017; 141 (7): 927–931. doi: https://doi.org/10.5858/arpa.2016-0307-RA #3: Kobe Ito A, Hayata Nishimura K, Ueda Y, Ishida Mycophenolate Mofetil-induced Diffuse Large B-cell Lymphoma Which Lung Nodule Remitted Spontaneously. Intern Med. 2021;60(1):131-136. doi:10.2169/internalmedicine.5027-20 DISCLOSURES: disclosure file Wei Bin; No relevant relationships Devashish Desai, source=Web Response Pushti Khandwala, Sachi Singhal,
منابع مشابه
Chronic diarrhoea from mycophenolate mofetil-induced colitis.
1 of 2 DESCRIPTION A 25-year-old female with mixed connective tissue disease (MCTD) complicated by scleroderma renal crisis presented with a 2-week history of profuse, watery diarrhoea that persisted through the night and with fasting. She has been maintained on mycophenolate mofetil (MMF) at 1000 mg/day for 1 year for her MCTD. The patient reported no recent travel or similar illness in her ho...
متن کاملMycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
Mycophenolate mofetil (MMF) as an immunosuppressive agent is used to prevent graft rejection. One of the adverse effects of long time administration of MMF is the gastrointestinal disorder. This study aimed to investigate the gastroprotective effect of silymarin (SMN) on MMF-induced gastrointestinal (GI) disorders. Twenty-four adult female Wistar rats were assigned into three groups including t...
متن کاملSilymarin attenuates mycophenolate mofetil-induced duodenal disorders in rats
Objective: The protective effect of silymarin (SMN) on mycophenolate mofetil (MMF)–induced duodenal disorders was investigated. Materials and Methods: Forty-two Wistar rats were assigned to seven groups including control and test groups. The control animals received saline and the test animals were treated with MMF (30 mg/kg, orally) and saline, MMF and SMN (25, 50, and 100 mg/kg, orally), MMF ...
متن کاملEffect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
Background. Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with ineffective treatment. Mycophenolate mofetil (MMF) is an immunomodulatory agent which inhibits lymphocyte proliferation. Objective. We sought to determine the safety and efficacy profile of MMF in IPF patients. Methods. We retrospectively identified ten patients, who met the ATS/ERS 2000 cri...
متن کاملEffectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
BACKGROUND Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and possesses important antiproliferative and antifibrotic effects. The safety and effectiveness of MMF i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2021
ISSN: ['0012-3692', '1931-3543']
DOI: https://doi.org/10.1016/j.chest.2021.07.1359